Advertisement

Topics

First-in-Human Trial will test a New Cancer Therapy from Switzerland

10:53 EDT 21 Aug 2017 | Labiotech.eu

Cellestia Biotech will start human trials with CB-103, an anticancer drug targeting the Notch signaling pathway, known for its ubiquity in cancer. Cellestia Biotech, based in Basel, has announced it received full approval to start clinical trials in Spain with CB-103, ...

This awesome article First-in-Human Trial will test a New Cancer Therapy from Switzerland appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: First-in-Human Trial will test a New Cancer Therapy from Switzerland

NEXT ARTICLE

More From BioPortfolio on "First-in-Human Trial will test a New Cancer Therapy from Switzerland"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...